Mets urged to pursue $79 million three-time All-Star, NL East rival to complement Juan Soto's power bat

Mets urged to pursue $79 million three-time All-Star, NL East rival to complement Juan Soto's power bat originally appeared ...
MedPage Today on MSN

Novel Complement-Targeting Agent Shows Benefit in Myasthenia Gravis

The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The trial tested two ...